Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Buy Shares of American Airlines Group Inc (AAL), Valeant Pharmaceuticals Intl Inc (VRX) & Two Other Stocks?

Philip Rosenstrach‘s Pomelo Capital is a New York-based investment fund that started its operations in 2012 after spinning off from Barclays’s capital arbitrage arm. The fund’s equity portfolio was valued at $2.17 billion at the end of September, compared to $1.97 billion at the end of the second quarter. Pomelo Capital’s long positions in companies worth at least $1.0 billion generated a weighted average return of 18.5% during the third quarter and it was ranked the 35th best performing hedge fund in our database. Hedge funds on average underperform the market in bull markets because they are hedged. In our rankings, we consider only their long positions in companies worth at least $1.0 billion. This way when we can compare these returns to the returns of the S&P 500 ETFs – which are basically 100% long portfolios of large-cap stocks – it is a straightforward apples-to-apples comparison.

Our approach reveals interesting facts about hedge funds’ stock picking skills. For instance, there were 659 hedge funds in our database that had at least 5 non-microcap stocks in their 13F portfolio. These hedge funds’ long portfolio managed to deliver an average return of 8.3% during the third quarter whereas S&P 500 ETFs returned only 3.3%. We should note that hedge fund investors didn’t see average gains of 8.3% in their statements for two reasons. First, most hedge funds are hedged. This means they make 8% on the long side of their portfolio but they lose money on the short side of their portfolio. Their net returns also shrink after taking into account their cash or debt positions that don’t usually return much in this environment. Second, we don’t like this and believe that hedge fund fees are excessive, most hedge funds charge an arm and a leg for their services. Net of hedging and fees, it isn’t surprising to see that hedge fund investors experience lower returns than index fund investors. If investors don’t want the downside protection that comes with investing in hedge funds and want to beat the market returns, they can consider investing in the individual stock picks successful hedge fund managers.

That’s why we will be looking at the stock picks of Pomelo Capital in this article.

Most Profitable Airlines In the World

Pomelo Capital had initiated a stake in American Airlines Group Inc (NASDAQ:AAL) during the second quarter, buying 527,000 shares of the company worth over $14.92 million at the end of June. However, in the third quarter, amid a 29.7% advance registered by the company’s stock, the fund cut the position by 57% to 224,800 shares worth $8.23 million at the end of September. Overall, American Airlines Group Inc (NASDAQ:AAL) saw 56 funds from our database holding shares at the end of June, down from 61 funds a quarter earlier. Among these funds, Adage Capital Management held the most valuable stake in American Airlines Group Inc (NASDAQ:AAL), which was worth $178.2 million at the end of the second quarter. On the second spot was Stelliam Investment Management which amassed $174 million worth of shares. Moreover, Masters Capital Management, Cyrus Capital Partners, and Highland Capital Management were also bullish on American Airlines Group Inc (NASDAQ:AAL).


Follow American Airlines Group Inc. (NYSE:AAL)
Trade (NYSE:AAL) Now!

Pomelo had upped its stake in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) by 68% in the second quarter, ending the period with a total of 724,900 shares of the company. In the third quarter, the stock appreciated by 21.9% and as the fund left the stake unchanged, its value went up to $17.80 million from $14.60 million. At the end of the second quarter, a total of 60 of the hedge funds tracked by Insider Monkey were long this stock, down by 15% from the previous quarter. Among these funds, Pershing Square held the most valuable stake in Valeant Pharmaceuticals Intl Inc (NYSE:VRX), which was worth $434.8 million at the end of the second quarter. On the second spot was Paulson & Co which amassed $384.1 million worth of shares. Moreover, ValueAct Capital, Okumus Fund Management, and Pentwater Capital Management were also bullish on Valeant Pharmaceuticals Intl Inc (NYSE:VRX).

Follow Bausch Health Companies Inc. (NYSE:BHC)
Trade (NYSE:BHC) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.